| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/13/1995 | WO1995009853A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009841A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 04/13/1995 | WO1995009653A1 Antibodies to cd40 |
| 04/13/1995 | WO1995009652A1 Treatment of autoimmune and inflammatory disorders |
| 04/13/1995 | WO1995009651A1 Improvements in and relating to vaccines |
| 04/13/1995 | WO1995009627A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
| 04/13/1995 | WO1995009624A1 Compounds, compositions and treatment of allergies and inflammation |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | CA2173460A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 04/13/1995 | CA2172124A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
| 04/12/1995 | EP0647219A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs. |
| 04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 04/12/1995 | EP0383764B1 Bovine granulocyte-macrophage colony stimulating factor |
| 04/12/1995 | CN1101260A Material for adjusting function of biology |
| 04/12/1995 | CN1028174C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/11/1995 | US5405988 9-substituted bicyclo[3.3.0]octane derivatives, process for their production and their pharmaceutical use |
| 04/11/1995 | US5405847 4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxalinones and corresponding aza analogs and a process for their preparation |
| 04/11/1995 | US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof |
| 04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995008991A1 Parenteral busulfan for treatment of malignant disease |
| 04/06/1995 | WO1995006718A3 Methods of suppressing autoimmune response |
| 04/06/1995 | WO1995006717A3 Methods of suppressing graft rejection |
| 04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
| 04/05/1995 | EP0646376A1 Immunomodulating and antiinflammatory agent |
| 04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 04/05/1995 | EP0646017A1 Immune suppressive product |
| 04/05/1995 | EP0646016A1 Synthetic peptides for the treatment of myasthenia gravis |
| 04/05/1995 | EP0646014A1 The use of hyperimmune milk to increase longevity |
| 04/05/1995 | EP0646004A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
| 04/05/1995 | CN1028106C Therapeutic nucleosides |
| 04/05/1995 | CN1028103C Piperidinyl benzimidazoles |
| 04/04/1995 | US5403930 Substituted salicylic acids |
| 04/04/1995 | US5403857 Enzyme inhibitors, antiallergens, antiinflammatory agents |
| 04/04/1995 | US5403851 Substituted tryptamines, phenalkylamines and related compounds |
| 04/04/1995 | US5403833 Methods of inhibiting transplant rejecton in mammals using rapamycin and derivatives and prodrugs thereof |
| 04/04/1995 | CA1335103C 5'-indolinyl-5beta-amidomethyloxazolidin-2-ones, 3-(fused-ring substituted) phenyl-5beta- amidomethyloxazolidin-2-ones and 3-(nitrogen substituted) phenyl-5beta-amidomethyloxazolidin-2-ones |
| 04/04/1995 | CA1335079C Preventive and curative agents for acquired immune deficiency syndrome (aids) |
| 04/03/1995 | EP0672152A4 Fusion proteins comprising mgf and il-3. |
| 03/31/1995 | CA2133180A1 Rapamycin formulation for iv injection |
| 03/30/1995 | WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites |
| 03/30/1995 | WO1995008572A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 03/30/1995 | WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 03/30/1995 | WO1995008564A1 PEPTIDE DERIVATIVES OF α-MSH AND THEIR APPLICATION |
| 03/30/1995 | WO1995008554A1 Nf-at polypeptides and polynucleotides |
| 03/30/1995 | WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 03/30/1995 | WO1995008355A1 Methods for enhancing vascularization of implant devices |
| 03/30/1995 | WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 03/30/1995 | WO1995008347A1 Methods and products for controlling immune responses in mammals |
| 03/30/1995 | WO1995003822A3 Use of relaxin as therapeutic or preventing agent |
| 03/30/1995 | WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 03/30/1995 | CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 03/30/1995 | CA2172287A1 Nf-at polypeptides and polynucleotides |
| 03/30/1995 | CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 03/30/1995 | CA2148354A1 Methods for enhancing vascularization of implant devices |
| 03/29/1995 | EP0645142A1 A novel physiologically active substance |
| 03/29/1995 | EP0645137A1 Use of quinones for the manufacture of a medicament for the treatment and prevention of a allergic rhinitis |
| 03/29/1995 | EP0644773A1 Anti-aids immunomodulator complex |
| 03/29/1995 | EP0644716A1 Medical uses of trioxolane and diperoxide compounds |
| 03/29/1995 | EP0403558B1 Antibodies for use in antilymphocyte antibody therapy |
| 03/29/1995 | EP0346427B1 Macrocyclic compounds |
| 03/28/1995 | US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments |
| 03/28/1995 | US5401777 Use of preparations of curcuma plants |
| 03/28/1995 | US5401727 Process for enhancing the resistance of aquatic animals to disease |
| 03/28/1995 | US5401725 Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia |
| 03/28/1995 | CA1334972C Pyridine-2,4- and -2,5-dicarboxylic acid amides, processes for their preparation, the use thereof, and medicaments based on these compounds |
| 03/28/1995 | CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
| 03/23/1995 | WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto |
| 03/23/1995 | WO1995007994A2 Recombinant alphavirus vectors |
| 03/23/1995 | WO1995007992A2 Cloned glutamic acid decarboxylase |
| 03/23/1995 | WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine |
| 03/23/1995 | WO1995007981A1 Grb3-3 gene, variants and uses thereof |
| 03/23/1995 | WO1995007934A2 Il8 inhibitors |
| 03/23/1995 | WO1995007933A1 Methods and composition for the modulation of host immune response to allergens |
| 03/23/1995 | WO1995007902A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 03/23/1995 | WO1995007886A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 03/23/1995 | WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 03/23/1995 | WO1995007707A1 Alteration of immune response using pan dr-binding peptides |
| 03/23/1995 | WO1995007706A1 The semaphorin gene family |
| 03/23/1995 | WO1995007696A1 Pharmaceutical composition of hiv-protease inhibitors |
| 03/23/1995 | DE4409671C1 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, viral or protozoal infections and for immunomodulation |
| 03/23/1995 | CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 03/23/1995 | CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 03/23/1995 | CA2169938A1 Grb3-3 gene; variants and uses thereof |
| 03/23/1995 | CA2167412A1 Pharmaceutical composition of hiv-protease inhibitors |
| 03/22/1995 | EP0644198A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors |
| 03/22/1995 | EP0644197A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors |
| 03/22/1995 | EP0643972A2 Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections and leukopenia |
| 03/22/1995 | EP0643769A1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II |
| 03/22/1995 | EP0643728A1 Icam-related protein |
| 03/22/1995 | EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 03/22/1995 | EP0643718A1 IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWIS?C AND LacNAc COMPOUNDS |
| 03/22/1995 | EP0643701A1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof |